• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈病患者外周趋化因子谱异常。

Abnormal peripheral chemokine profile in Huntington's disease.

作者信息

Wild Edward, Magnusson Anna, Lahiri Nayana, Krus Ulrika, Orth Michael, Tabrizi Sarah J, Björkqvist Maria

机构信息

UCL Institute of Neurology, London, UK; Bristol University, UK; Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund University, Lund, Sweden; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK; Lund University Diabetes Center Malmö Sweden and Department of Neurology, University of Ulm, Ulm, Germany.

出版信息

PLoS Curr. 2011 Apr 13;3:RRN1231. doi: 10.1371/currents.RRN1231.

DOI:10.1371/currents.RRN1231
PMID:21826115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3082446/
Abstract

Huntington's disease (HD) is an inherited neurodegenerative disorder characterized by both neurological and systemic abnormalities. Immune activation is a well-established feature of the HD brain and we have previously demonstrated a widespread, progressive innate immune response detectable in plasma throughout the course of HD. In the present work we used multiplex ELISA to quantify levels of chemokines in plasma from controls and subjects at different stages of HD. We found an altered chemokine profile tracking with disease progression, with significant elevations of five chemokines (eotaxin-3, MIP-1β, eotaxin, MCP-1 and MCP-4) while three (eotaxin-3, MIP-1β and eotaxin) showed significant linear increases across advancing disease stages. We validated our results in a separate sample cohort including subjects at different stages of HD. Here we saw that chemokine levels (MCP-1 and eotaxin) correlated with clinical scores. We conclude that, like cytokines, chemokines may be linked to the pathogenesis of HD, and that immune molecules may be valuable in tracking and exploring the pathogenesis of HD.

摘要

亨廷顿舞蹈症(HD)是一种遗传性神经退行性疾病,其特征为神经和全身异常。免疫激活是HD大脑的一个公认特征,我们之前已经证明,在HD病程中,血浆中可检测到广泛的、进行性的先天免疫反应。在本研究中,我们使用多重酶联免疫吸附测定(ELISA)来量化对照人群以及HD不同阶段受试者血浆中的趋化因子水平。我们发现趋化因子谱随疾病进展而改变,五种趋化因子(嗜酸性粒细胞趋化因子-3、巨噬细胞炎性蛋白-1β、嗜酸性粒细胞趋化因子、单核细胞趋化蛋白-1和单核细胞趋化蛋白-4)显著升高,而其中三种(嗜酸性粒细胞趋化因子-3、巨噬细胞炎性蛋白-1β和嗜酸性粒细胞趋化因子)在疾病进展阶段呈显著线性增加。我们在另一个包括HD不同阶段受试者的样本队列中验证了我们的结果。在此我们发现趋化因子水平(单核细胞趋化蛋白-1和嗜酸性粒细胞趋化因子)与临床评分相关。我们得出结论,与细胞因子一样,趋化因子可能与HD的发病机制有关,并且免疫分子在追踪和探索HD的发病机制方面可能具有重要价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7548/3082446/e80ca6c70c4b/bild3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7548/3082446/18fdb3f46ac6/bjorkqvist-figure-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7548/3082446/9a427a8e5664/bjorkqvist-figure-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7548/3082446/e80ca6c70c4b/bild3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7548/3082446/18fdb3f46ac6/bjorkqvist-figure-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7548/3082446/9a427a8e5664/bjorkqvist-figure-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7548/3082446/e80ca6c70c4b/bild3.jpg

相似文献

1
Abnormal peripheral chemokine profile in Huntington's disease.亨廷顿舞蹈病患者外周趋化因子谱异常。
PLoS Curr. 2011 Apr 13;3:RRN1231. doi: 10.1371/currents.RRN1231.
2
Oxidative stress influences CC-chemokine levels in hemodialyzed patients.氧化应激影响血液透析患者的CC趋化因子水平。
Nephron Physiol. 2004;96(4):p105-12. doi: 10.1159/000077381.
3
Circulating Levels of the Adipokines Monocyte Chemotactic Protein-4 (MCP-4), Macrophage Inflammatory Protein-1β (MIP-1β), and Eotaxin-3 in Severe Obesity and Following Bariatric Surgery.重度肥胖及减肥手术后脂肪因子单核细胞趋化蛋白-4(MCP-4)、巨噬细胞炎性蛋白-1β(MIP-1β)和嗜酸性粒细胞趋化因子-3的循环水平
Horm Metab Res. 2016 Dec;48(12):847-853. doi: 10.1055/s-0042-108731. Epub 2016 Jun 14.
4
A critical evaluation of inflammatory markers in Huntington's Disease plasma.亨廷顿舞蹈病血浆中炎症标志物的批判性评估
J Huntingtons Dis. 2013;2(1):125-34. doi: 10.3233/JHD-130049.
5
Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury.炎症细胞因子和趋化因子谱与急性脑损伤后的患者预后及高肾上腺素能状态相关。
J Neuroinflammation. 2016 Feb 16;13:40. doi: 10.1186/s12974-016-0500-3.
6
Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial.低剂量阿托伐他汀治疗可降低代谢综合征患者循环CC趋化因子水平:一项随机对照试验的证据
Clin Endocrinol (Oxf). 2013 Dec;79(6):800-6. doi: 10.1111/cen.12113. Epub 2013 Apr 27.
7
Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis.特应性皮炎患者中CC趋化因子(RANTES、MCP-1、MIP-1α、MIP-1β和嗜酸性粒细胞趋化因子)的产生增加。
Arch Dermatol Res. 2001 Jul;293(7):350-5. doi: 10.1007/s004030100230.
8
Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia.
Blood. 1999 Apr 15;93(8):2463-70.
9
CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist.CCR5可结合多种CC趋化因子:MCP-3作为一种天然拮抗剂。
Blood. 1999 Sep 15;94(6):1899-905.
10
Regulatory effects of eotaxin on acute lung inflammatory injury.嗜酸性粒细胞趋化因子对急性肺炎症性损伤的调节作用。
J Immunol. 2001 Apr 15;166(8):5208-18. doi: 10.4049/jimmunol.166.8.5208.

引用本文的文献

1
Neuroinflammatory mechanisms may help identify candidate biomarkers in chronic traumatic encephalopathy (CTE).神经炎症机制可能有助于识别慢性创伤性脑病(CTE)中的候选生物标志物。
Free Neuropathol. 2025 Jul 14;6:15. doi: 10.17879/freeneuropathology-2025-6382. eCollection 2025.
2
CCL11 (Eotaxin) Promotes the Advancement of Aging-Related Cardiovascular Diseases.CCL11(嗜酸性粒细胞趋化因子)促进衰老相关心血管疾病的进展。
Rev Cardiovasc Med. 2025 Feb 13;26(2):26020. doi: 10.31083/RCM26020. eCollection 2025 Feb.
3
Advances in Huntington's Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review.

本文引用的文献

1
Interferon gamma-inducible protein-10 (IP-10) and eotaxin as biomarkers in age-related macular degeneration.干扰素γ诱导蛋白-10(IP-10)和嗜酸性粒细胞趋化因子作为与年龄相关的黄斑变性的生物标志物。
Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4226-36. doi: 10.1167/iovs.09-3910. Epub 2010 Mar 10.
2
Immune activation in brain aging and neurodegeneration: too much or too little?大脑衰老和神经退行性变中的免疫激活:过度还是不足?
Neuron. 2009 Oct 15;64(1):110-22. doi: 10.1016/j.neuron.2009.08.039.
3
Harnessing immune alterations in neurodegenerative diseases.
亨廷顿舞蹈症生物标志物的进展:十年文献计量分析与综合综述
Biology (Basel). 2025 Jan 26;14(2):129. doi: 10.3390/biology14020129.
4
The Impact of Aging on Neurological Diseases in the Elderly: Molecular Mechanisms and Therapeutic Perspectives.衰老对老年人神经系统疾病的影响:分子机制与治疗前景
Aging Dis. 2024 Nov 5;16(5):2953-2978. doi: 10.14336/AD.2024.1085.
5
Role of Thrombosis in Neurodegenerative Diseases: An Intricate Mechanism of Neurovascular Complications.血栓形成在神经退行性疾病中的作用:神经血管并发症的复杂机制
Mol Neurobiol. 2025 Apr;62(4):4802-4836. doi: 10.1007/s12035-024-04589-4. Epub 2024 Nov 1.
6
The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions.白细胞介素-6(IL-6)及间充质干细胞源性IL-6对神经系统疾病的影响。
Front Immunol. 2024 Jun 24;15:1400533. doi: 10.3389/fimmu.2024.1400533. eCollection 2024.
7
Intravenous MSC-Treatment Improves Impaired Brain Functions in the R6/2 Mouse Model of Huntington's Disease via Recovered Hepatic Pathological Changes.静脉内间充质干细胞治疗通过恢复肝组织病理学变化改善亨廷顿病 R6/2 小鼠模型的受损脑功能。
Cells. 2024 Mar 7;13(6):469. doi: 10.3390/cells13060469.
8
Mutant huntingtin protein induces MLH1 degradation, DNA hyperexcision, and cGAS-STING-dependent apoptosis.突变型亨廷顿蛋白诱导 MLH1 降解、DNA 超切割和 cGAS-STING 依赖性细胞凋亡。
Proc Natl Acad Sci U S A. 2024 Mar 26;121(13):e2313652121. doi: 10.1073/pnas.2313652121. Epub 2024 Mar 18.
9
Lowering mutant huntingtin by small molecules relieves Huntington's disease symptoms and progression.小分子降低突变型亨廷顿蛋白可缓解亨廷顿病的症状和进展。
EMBO Mol Med. 2024 Mar;16(3):523-546. doi: 10.1038/s44321-023-00020-y. Epub 2024 Feb 19.
10
The Emerging Landscape of Natural Small-molecule Therapeutics for Huntington's Disease.治疗亨廷顿舞蹈病的天然小分子治疗药物的新兴领域。
Curr Neuropharmacol. 2023;21(4):867-889. doi: 10.2174/1570159X21666230216104621.
利用神经退行性疾病中的免疫改变。
Neuron. 2009 Oct 15;64(1):21-4. doi: 10.1016/j.neuron.2009.09.034.
4
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.亨廷顿舞蹈病纵向TRACK-HD研究中的生物学和临床表现:基线数据的横断面分析
Lancet Neurol. 2009 Sep;8(9):791-801. doi: 10.1016/S1474-4422(09)70170-X. Epub 2009 Jul 29.
5
Beyond the brain: widespread pathology in Huntington's disease.超越大脑:亨廷顿舞蹈症的广泛病变
Lancet Neurol. 2009 Aug;8(8):765-74. doi: 10.1016/S1474-4422(09)70178-4.
6
Multiplex analysis of cytokines in the serum and cerebrospinal fluid of patients with Alzheimer's disease by color-coded bead technology.采用彩色编码珠技术对阿尔茨海默病患者血清和脑脊液中的细胞因子进行多重分析。
J Clin Neurol. 2008 Jun;4(2):84-8. doi: 10.3988/jcn.2008.4.2.84. Epub 2008 Jun 20.
7
Neuro-immune crosstalk in CNS diseases.中枢神经系统疾病中的神经免疫相互作用
Results Probl Cell Differ. 2010;51:197-216. doi: 10.1007/400_2009_6.
8
Induction of chemokines, MCP-1, and KC in the mutant huntingtin expressing neuronal cells because of proteasomal dysfunction.由于蛋白酶体功能障碍,在表达突变亨廷顿蛋白的神经元细胞中诱导趋化因子、单核细胞趋化蛋白-1(MCP-1)和角质形成细胞趋化因子(KC)。
J Neurochem. 2009 Feb;108(3):787-95. doi: 10.1111/j.1471-4159.2008.05823.x.
9
Peripheral cytokines profile in Parkinson's disease.帕金森病中的外周细胞因子谱
Brain Behav Immun. 2009 Jan;23(1):55-63. doi: 10.1016/j.bbi.2008.07.003. Epub 2008 Jul 17.
10
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease.一种在亨廷顿舞蹈症临床发病前即可检测到的新型免疫激活致病途径。
J Exp Med. 2008 Aug 4;205(8):1869-77. doi: 10.1084/jem.20080178. Epub 2008 Jul 14.